Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
09/17/2008 | CN100419075C Hybridoma cell strain capable of excreting monoclonal antibody of human carboxylesterase 2 and monoclonal antibody of human carboxylesterase 2 |
09/17/2008 | CN100418984C N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
09/16/2008 | US7425622 Antibodies against C3a receptor |
09/16/2008 | US7425621 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
09/16/2008 | US7425620 FcγRIIB-specific antibodies and methods of use thereof |
09/16/2008 | US7425619 FcγRIIB specific antibodies and methods of use thereof |
09/16/2008 | US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
09/16/2008 | US7425617 Antibodies to the cell cycle regulatory protein p16 |
09/16/2008 | US7425613 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
09/16/2008 | US7425609 PRO4330 polypeptides |
09/16/2008 | US7425605 PRO1486 polypeptides |
09/16/2008 | US7425540 Method for modification of NMDA receptors through inhibition of Src |
09/16/2008 | US7425450 Regulatable growth of filamentous fungi |
09/16/2008 | US7425435 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
09/16/2008 | US7425434 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
09/16/2008 | US7425433 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
09/16/2008 | US7425429 Method for the identification of tissue-specific regulatory sequences |
09/16/2008 | US7425423 Catalyzes template directed polymerization of DNA, possesses 3'-5'-exonuclease (proofreading) activity and is characterized by at least two-fold greater replication fidelity the DNA polymerase obtainable from Pyrococcus furiosus; dodecylpolyethylene glycol and/or ethylphenolpolyethylene glycol stabilizer |
09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
09/16/2008 | US7425329 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
09/16/2008 | CA2467801C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |
09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
09/16/2008 | CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease |
09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
09/12/2008 | WO2008109410A1 Use of copper and glutamate in cell culture for production of polypeptides |
09/12/2008 | WO2008109398A1 T4 bacteriophage bound to a substrate |
09/12/2008 | WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
09/12/2008 | WO2008108345A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |
09/12/2008 | WO2008108325A1 Novel beta-galactoside-alpha-2,6-sialyltransferase, gene encoding the same and method for enhancing enzymatic activity |
09/12/2008 | WO2008079359A3 Human antibodies that bind human il-12 and methods for producing |
09/12/2008 | WO2008033520A3 Bifidobacterial gene sequences and their use |
09/12/2008 | WO2006076041A3 Pan-her antagonists and methods of use |
09/12/2008 | CA2679941A1 Use of copper and glutamate in cell culture for production of polypeptides |
09/12/2008 | CA2679926A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |
09/12/2008 | CA2679703A1 A novel .beta.-galactoside-.alpha.2,6-sialyltransferase, a gene encoding thereof, and a method for enhancing enzyme activity |
09/11/2008 | US20080222756 Nucleic acid constructs and methods for producing altered seed oil compositions |
09/11/2008 | US20080222740 Improved properties such as temperature and/or pH stability, pH activity profile, temperature activity profile, substrate profile, improved performance in animal feed in vitro or in vivo |
09/11/2008 | US20080222739 Cwp84, FliC and FliD proteins known to have conserved peptide sequences separately injected into female chickens, and the antibody rich egg yolks harvested |
09/11/2008 | US20080221311 Preparation method of insect cell extract solution for cell-free protein synthesis, the insect cell extract solution and cell-free synthesis method of protein using the insect cell extract solution |
09/11/2008 | US20080221309 MN Gene and Protein |
09/11/2008 | US20080221305 Polynucleotides encoding novel adiponectin receptor variants |
09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
09/11/2008 | US20080220480 Removing H2O from atmospheric air, obtaining H2 from the H2O, obtaining CO2 from the air, and converting the CO2 to methanol; the methanol can be dehydrated to produce dimethyl ether or further processed to produce synthetic hydrocarbons, polymers, and other products; fossil fuel alternative |
09/11/2008 | US20080220479 Expression vector comprising nucleotide sequences coding cytokine receptor specific immunoglobulin for treatment and prevention of inflammation, cartilage degradation and bone resorption |
09/11/2008 | US20080220478 Using transgenic cell as bioreactor for propagating multimeric proteins |
09/11/2008 | US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis |
09/11/2008 | US20080220476 Thermostable Alpha-Amylases |
09/11/2008 | US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS |
09/11/2008 | US20080220474 Using transgenic yeast comprising omega -3 and/or omega -6 fatty acid promoters as bioreactor for heterologous gene expression |
09/11/2008 | US20080220473 Endo-N-Acetyl-Beta-D-Glucosaminidase Enzymes of Filamentous Fungi |
09/11/2008 | US20080220472 In Vivo Incorporation of Alkynyl Amino Acids into Proteins in Eubacteria |
09/11/2008 | US20080220471 Nucleotide sequences coding Tet repressor (TetR) protein for use as gene targeting tool in genetic engineering |
09/11/2008 | US20080220470 Protein hydrolysate rich in tripeptides |
09/11/2008 | US20080220460 Modified flavin adenine dinucleotide dependent glucose dehydrogenase |
09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
09/11/2008 | US20080220431 Cell fusion method |
09/11/2008 | US20080220417 Novel Alanine Transaminase Enzymes and Methods of Use |
09/11/2008 | US20080220410 Method for replicating the hepatitis c virus |
09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
09/11/2008 | US20080219997 Her-2 binding antagonists |
09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
09/11/2008 | US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
09/11/2008 | US20080219952 culturing a human interferon producing cells in a serum-free medium, comprising hydroxyethyl piperazinyl ethanesulfonic acid(HEPES), proline sodium chloride and phenol red; drugs used for treating multiple sclerosis, viral diseases or cancer |
09/11/2008 | US20080219925 Delta opioid receptor protein |
09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
09/10/2008 | EP1967585A1 Method for gene amplification |
09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
09/10/2008 | EP1967524A1 Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby |
09/10/2008 | EP1966388A2 Targeting vector-phospholipid conjugates |
09/10/2008 | EP1819816B1 Methods for the production and secretion of modified peptides |
09/10/2008 | EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments |
09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
09/10/2008 | EP1412504B1 Methods of rna and protein synthesis |
09/10/2008 | EP1401851B8 Two-stage protective groups for the synthesis of biopolymers |
09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
09/10/2008 | EP1127154B1 Method for the production of fvii |
09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
09/10/2008 | EP0832245B2 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
09/10/2008 | CN101260421A Method for preparing whey protein peptide by composite protease hydrolysis |
09/10/2008 | CN101260420A Method for preparing protein filling material for leather preparation by using leather preparation barilla leather leftover material as raw material |
09/10/2008 | CN101260401A Gene encoding a marker for cancer |
09/10/2008 | CN101260397A Immobilization proteinase and application method thereof in preparing cream protein peptide |
09/10/2008 | CN101260156A Immunoglobulin single variant antigen binding domain and specific construct thereof |
09/10/2008 | CN101260149A Streptococcus antigens |